Skip to main content
Minnesota Department of Health logo
  • Main navigation

    • Home
    • Data, Statistics, and Legislation
    • Diseases and Conditions
    • Health Care Facilities, Providers, and Insurance
    • Healthy Communities, Environment, and Workplaces
    • Individual and Family Health
    • About Us
    • News and Announcements
    • Translated Materials

Main navigation mobile

  • Data, Statistics, and Legislation
  • Diseases and Conditions
  • Health Care Facilities, Providers, and Insurance
  • Healthy Communities, Environment, and Workplaces
  • Individual and Family Health
  • About Us
  • News and Announcements
  • Translated Materials
MDH Logo

Breadcrumb

  1. Home
  2. Diseases and Conditions
  3. Staphylococcus Aureus (S. Aureus or “staph”)
  4. Methicillin-resistant Staphylococcus Aureus (MRSA)
Topic Menu

MRSA

  • MRSA Home
  • About MRSA
  •  -  CA-MRSA
  •  -  HA-MRSA
  • MRSA Surveillance and Reporting
  • MRSA Recommendations
  • MRSA Guidelines and Resources

MRSA

  • MRSA Home
  • About MRSA
  •  -  CA-MRSA
  •  -  HA-MRSA
  • MRSA Surveillance and Reporting
  • MRSA Recommendations
  • MRSA Guidelines and Resources
Contact Info
Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

Contact Info

Infectious Disease Epidemiology, Prevention and Control Division
651-201-5414
IDEPC Comment Form

MRSA Guidelines and Resources

Infection Prevention and Control Guidelines

  • Infection Prevention and Control Guidelines
    General infection prevention guidelines, recommendations, and laws related to infection prevention.

Staph and MRSA Guidelines and Recommendations

For health care facilities

  • Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Fact Sheet for Healthcare Providers
    Case-definition of CA-MRSA, Spectrum, Diagnosis and treatment, Prevention (keeping CA-MRSA from turning into HA-MRSA), Prevention (keeping CA-MRSA from spreading in communities)


     
  • CDC: Multidrug-resistant Organisms (MDRO) Management Guidelines
    CDC guidelines to prevent and control MDROs such as MRSA and VRE in health care facilities.
  • CDC: About Antimicrobial Resistance Investments & Action
    The CDC's Campaign to Prevent Antimicrobial Resistance aims to prevent antimicrobial resistance in health care settings. The campaign centers on four main strategies: prevent infection, diagnose and treat infection, use antimicrobials wisely, and prevent transmission.
  • CID: Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children 
    Evidence-based guidelines for the management of patients with MRSA infections prepared by the Infectious Diseases Society of America. The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections.

For laboratories

  • CDC: Laboratory Detection of Oxacillin/Methicillin-resistant Staphylococcus aureus (MRSA)
    MRSA fact sheet for laboratories from the CDC.
     

For athletes

  • MRSA: Information for Coaches and Athletes

For prisons

  • MRSA: Information for Correctional Facilities

References

  • Comparison of Community- and Health Care–Associated Methicillin-Resistant Staphylococcus aureus Infection
    JAMA. 2003;290:2976-2984. Timothy S. Naimi, Kathleen H. LeDell, Kathryn Como-Sabetti, et al.

     
  • Four Pediatric Deaths from Community-Acquired Methicillin-Resistant Staphylococcus aureus -- Minnesota and North Dakota, 1997-1999
    MMWR; August 20, 1999. Pediatric MRSA cases.
Tags
  • staph
Last Updated: 05/21/2024

Get email updates


Minnesota Department of Health logo

Privacy Policy
Equal Opportunity
Translated Materials
Feedback Form
About MDH
Minnesota.gov
  • Facebook
  • Twitter
  • Linked In
  • Instagram
  • Youtube
Minnesota Department of Health Minnesota Department of health print search share facebook instagram linkedin twitter youtube